Literature DB >> 2346980

[Treatment with autovaccines and the immunologic profile of patients].

Z Novotný1, J Krupicka, I Hánová, E Rys.   

Abstract

In a group of 33 patients with chronic inflammations of the upper airways and deglutition pathways the effect of treatment with autovaccines in the form of nasal drops was investigated. In 77.7% a therapeutic success was recorded still after an interval of 1-3 years following termination of treatment. In the entire group parameters of humoral and cellular immunity were tested. In none of the patients severe forms of immunodeficiency were found. In 16 patients an immunological check-up was made after termination of autovaccine treatment. Although differences were revealed in the immunological picture, none of them attained the level of statistical significance. The action of autovaccines could be explained by the non-specific action of bacterins. Common immunological examinations methods are so far unable to define all cooperative relations between different immunocompetent cells and systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346980

Source DB:  PubMed          Journal:  Cesk Otolaryngol        ISSN: 0009-0603


  2 in total

1.  Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus.

Authors:  S Holtfreter; J Jursa-Kulesza; H Masiuk; N J Verkaik; C de Vogel; J Kolata; M Nowosiad; L Steil; W van Wamel; A van Belkum; U Völker; S Giedrys-Kalemba; B M Bröker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-22       Impact factor: 3.267

2.  Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma--a prospective open clinical trial.

Authors:  Markus A Rose; Bianca Weigand; Ralf Schubert; Johannes Schulze; Stefan Zielen
Journal:  BMC Complement Altern Med       Date:  2011-06-03       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.